We are live on ! Find out more
CM

Castleark Management Portfolio holdings

AUM $3.02B
1-Year Est. Return 53.92%
This Fund
S&P 500
This Quarter Est. Return
-13.81%
1 Year Est. Return
+53.92%
3 Year Est. Return
+208.37%
5 Year Est. Return
+342.22%
10 Year Est. Return
+3,246.09%
AUM
$2.35B
AUM Growth
-$1.13B
Cap. Flow
-$606M
Cap. Flow %
-25.82%
Top 10 Hldgs %
20.13%
Holding
428
New
59
Increased
50
Reduced
162
Closed
63

Top Buys

Rank Stock Value
1
BA icon
Boeing
BA
+$39M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$31.8M
3
ULTA icon
Ulta Beauty
ULTA
+$26.8M
4
CRM icon
Salesforce
CRM
+$24.1M
5
MRK icon
Merck
MRK
+$22.5M

Top Sells

Rank Stock Value
1
UNP icon
Union Pacific
UNP
+$30.8M
2
ATVI
Activision Blizzard
ATVI
+$29.7M
3
XPO icon
XPO
XPO
+$29M
4
VLO icon
Valero Energy
VLO
+$28.2M
5
AAPL icon
Apple
AAPL
+$28.1M

Sector Composition

Rank Sector Weight
1 Healthcare 21.82%
2 Technology 14.54%
3 Consumer Discretionary 13.17%
4 Industrials 11.82%
5 Financials 10.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTNT icon
251
Fortinet
FTNT
$112B
$1.32M 0.06%
93,625
-36,900
-28% -$562K
B
252
Barrick Mining
B
$60.9B
$1.25M 0.05%
92,500
SRPT icon
253
Sarepta Therapeutics
SRPT
$1.64B
$1.25M 0.05%
11,430
-69,875
-86% -$8.74M
TTE icon
254
TotalEnergies
TTE
$193B
$1.23M 0.05%
23,540
-37,270
-61% -$2.14M
RPM icon
255
RPM International
RPM
$13.8B
$1.19M 0.05%
20,240
DKS icon
256
Dick's Sporting Goods
DKS
$18.4B
$1.14M 0.05%
36,600
NBIX icon
257
Neurocrine Biosciences
NBIX
$18.2B
$1.13M 0.05%
15,775
-30,890
-66% -$2.96M
SSNC icon
258
SS&C Technologies
SSNC
$18.9B
$1.1M 0.05%
24,415
-24,186
-50% -$1.17M
MYOK
259
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$1.1M 0.05%
+22,540
New +$1.24M
FFIV icon
260
F5
FFIV
$22B
$1.03M 0.04%
6,380
ENBL
261
DELISTED
ENABLE MIDSTREAM PARTNERS, LP
ENBL
$963K 0.04%
71,200
CHRD icon
262
Chord Energy
CHRD
$7.68B
$960K 0.04%
173,590
-630
-0.4% -$5.72K
PAYX icon
263
Paychex
PAYX
$43.4B
$960K 0.04%
14,740
RRC icon
264
Range Resources
RRC
$9.33B
$955K 0.04%
99,800
SRCL
265
DELISTED
Stericycle Inc
SRCL
$950K 0.04%
25,890
AMD icon
266
Advanced Micro Devices
AMD
$700B
$943K 0.04%
51,110
-101,140
-66% -$2.19M
VLO icon
267
Valero Energy
VLO
$89.5B
$920K 0.04%
12,270
-320,641
-96% -$28.2M
TSM icon
268
TSMC
TSM
$1.94T
$854K 0.04%
23,130
-23,130
-50% -$880K
UA icon
269
Under Armour Class C
UA
$2.95B
$819K 0.03%
50,656
UAA icon
270
Under Armour
UAA
$3.01B
$800K 0.03%
45,300
ENLK
271
DELISTED
EnLink Midstream Partners, LP
ENLK
$790K 0.03%
71,750
GDS icon
272
GDS Holdings
GDS
$5.93B
$782K 0.03%
33,860
-33,860
-50% -$883K
PRAA icon
273
PRA Group
PRAA
$672M
$773K 0.03%
31,710
BPL
274
DELISTED
Buckeye Partners, L.P.
BPL
$761K 0.03%
26,261
LKFT
275
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.82B
$760K 0.03%
8,280
-4,480
-35% -$454K

Similar funds

Castleark Management's Q4 2018 Portfolio in Review

As of Q4 2018, Castleark Management held 428 positions worth $2.35B, down 33% from $3.48B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Castleark Management withdrew a net $606M in Q4 2018, closing 63 positions and reducing 162 holdings. Its most notable exit was Union Pacific, an estimated $30.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 24% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Castleark Management opened a new position in Ulta Beauty worth $23.8M.

  • Castleark Management's largest Q4 2018 buy was Ulta Beauty: 97,081 shares worth $23.8M.
  • Castleark Management added most to Boeing in Q4 2018, an estimated $39M increase.
  • Castleark Management's biggest Q4 2018 reduction was XPO, cutting an estimated $29M.
  • Castleark Management fully exited Union Pacific in Q4 2018, selling an estimated $30.8M.
  • Castleark Management's ten largest holdings make up 20% of its $2.35B portfolio in Q4 2018.
  • Castleark Management opened 59 new positions and closed 63 in Q4 2018.
  • Castleark Management's portfolio value fell 33% quarter-over-quarter to $2.35B.

Based on Castleark Management's 13F filing for Q4 2018, filed 12 Feb 2019.